mcas and semaglutide Can GLP-1 Medications Help MCAS, Fatigue, More? Low-Dose GLP-1 Inhibitors for Mast

Kim insisted that she 'didn't do anything unhealthy' to achieve her goal

Do you gain the weight back after you stop treatment

If you have a history of eating disorders, you are entitled to a referral to both an eating disorders specialist and an obesity medicine specialist ( Mozaffarian et al., Am J Clinical Nutrition, 2025 )

Cardiovascular Effects While Ozempic has been shown to reduce the risk of major cardiovascular events in patients with Type 2 diabetes, there is limited data on its long-term impact on heart health

Used to be, Id treat myself to sushi or queso after a bad day

Wegovy has the strongest cardiovascular evidence of any GLP-1 medication thanks to the SELECT trial, which demonstrated a 20% reduction in major adverse cardiac events (heart attack, stroke, and cardiovascular death) in people with obesity and established heart disease